The Limited Times

Now you can see non-English news...

WuXi PharmaTech announces shareholders' plans to reduce A shares, A shares and H shares

2020-03-30T03:06:25.146Z


WuXi PharmaTech (2359) once fell 9%, seeing 89.8 yuan, the price was a week low, now it is 8.5%, the turnover was 48.2 million yuan. Its A shares (603259.SH) fell 7.17%. Group announced that shareholder WXAT BVI (Wuxi Kangde Viking


Financial news

Written by: Huang Youhua

2020-03-30 10:57

Last updated: 2020-03-30 10:57

WuXi PharmaTech (2359) announced that some shareholders intend to reduce their holdings of A shares. This morning, both A and H shares fell. H shares have fallen 9%, seeing 89.8 yuan, the price is a week low, the latest reported 91.5 yuan, down 7.2%, turnover was 69 million yuan; its A shares (Shanghai (603259) fell 6.7%.

The Group announced that shareholders WXAT BVI (Wuxi Kangde Viking) will reduce the holding of A shares at market prices through auctions from April 21 to July 19, the number of which does not exceed approximately 16.65 million A shares, accounting for issued shares The total number of shares does not exceed 1%.

The group's net profit for the year ended December 31 last year was approximately 1.855 billion yuan, a year-on-year decrease of approximately 18%, and earnings per share were 1.14 yuan. A final dividend of 33.7 cents per share was issued. At the same time, the reserve was transferred to share capital, and every 10 shares held by shareholders Increase 4 shares.

[Transferring Shares] Adway Announces Two-Month Listing

[Transaction stock] China Feihe's net profit increased by 75%

[Moving stocks] Li Ning made 1.1 times more last year, up 19%

Transaction stock WuXi PharmaTech A shares

Source: hk1

All news articles on 2020-03-30

You may like

News/Politics 2024-04-04T16:19:08.773Z

Trends 24h

News/Politics 2024-04-18T09:29:37.790Z
News/Politics 2024-04-18T11:17:37.535Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.